title: [Histiocytosis of the Langerhans cells with cerebellar and pyramidal involvement. Response to treatment with chemotherapy].
authors.forename: E
authors.initials: E
authors.lastname: Martínez-Fernández
authors.forename: E
authors.initials: E
authors.lastname: Gil-Néciga
authors.forename: J M
authors.initials: JM
authors.lastname: López-Domínguez
authors.forename: J L
authors.initials: JL
authors.lastname: Casado-Chocán
authors.forename: F
authors.initials: F
authors.lastname: Garzón
authors.forename: E
authors.initials: E
authors.lastname: Franco
authors.forename: M V
authors.initials: MV
authors.lastname: Abrio
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002524:Cerebellar Ataxia / Q000150:complications / Q000175:diagnosis*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D011712:Pyramidal Tracts / Q000473:pathology*; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D018906:Antineoplastic Agents, Alkylating; D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone